اللهم إني أبرا من حولي وقوتي والتجئ إلى حولك وقوتك فلا حول لي ولا قوةً إلا بك، ربِ ناديتك بقلب يملئه الأمل بالأجابة فلا ترد لي دعاء، اللهم حقق لي كل دعوةً أعتدت تكرارها، يارب أفرح قلبّي بما أردت.
يُسعدنا أن نُعلن عن عودة مؤتمر التخصصات الصحيّة الثامن والذي سيُقام في شهر مارس المُقبل بإذن الله، كونوا على اِستعداد!⏳
#مؤتمر_التخصصات_الصحية_٢٠٢٤ | #HPC2024
الحمدلله الذي بنعمته تتم الصالحات ❤️❤️
أحب أشكر كل من ساهم في كسبي لهذا الفوز ، وإن شاءالله القادم افضل✨
شكر خاص إلى دكتورتي و مرشدتي د. أثير ❤️
@AtheerAldairem
📢 📚 🔬 We are happy to share the latest findings from our study at the Saudi Critical Care Pharmacy Research (SCAPE) platform @SCAPE_Platform , titled "When antivirals backfire: An evaluation of favipiravir's clinical outcomes in critically ill patients with COVID-19: A multicenter cohort study." 🌐
In this groundbreaking study, our aim was to assess the effectiveness and safety of favipiravir in critically ill patients with COVID-19. We understand the pressing need to identify optimal treatment strategies for this vulnerable population and improve patient outcomes. 🩺💊
After meticulous analysis of the data, we have discovered some noteworthy results. Unfortunately, the use of favipiravir in critically ill patients with COVID-19 did not demonstrate a reduction in mortality as we had hoped. Instead, we found an unexpected association with longer mechanical ventilation duration and extended stays in the intensive care unit (ICU). 📉🏥
While this antiviral has shown effectiveness in other infections, our study suggests that its benefits in the context of COVID-19 may be limited. However, it is important to emphasize that our study is just one piece of the puzzle. Further randomized clinical trials are essential to confirm these findings and provide a comprehensive understanding of the effectiveness and safety profile of favipiravir in critically ill patients with COVID-19. 🔬🔍
We believe that our study's outcomes have significant implications for clinical practice. By shedding light on the potential limitations of favipiravir in critically ill COVID-19 patients, we can guide healthcare professionals in making informed decisions and tailoring their treatment strategies. 💡🌟
I would like to express my deepest gratitude to the entire team at @SCAPE_Platform for their unwavering dedication and hard work in conducting this study. Their commitment to advancing critical care pharmacy research is truly commendable. 👏🌍
@DrOhoudAljuhani
@GhazwaTbader@Altebainawi@MashaelAlfaifi@mhn1414hn@DrAlhajaji@AbrarThabit@_alenaziar@AlharbiAisha_
Dr. Alaa Almagthali
Dr. Reham Alharbi
Dr. Munirah M Alghwainm
Dr. Ramesh Vishwakarma
Special thanks for our extraordinary pharmacy interns and students @KSAU_HS_COP for their dedication and commitment: Khawla Kahtani, Sara M. Alotaibi, Yazeed S. Alghamdi, Shaden H. Alonazi, Jumanah M. Almutairi
Please feel free to reach out if you have any questions or would like to learn more about our study. I am excited to continue this important journey and contribute to the advancement of critical care pharmacy research. Together, we can make a difference! 👥💪
https://t.co/sV1BmrELfy
#COVID19Research #ClinicalOutcomes #CriticalCarePharmacy #SCAPE #Favipiravir #HealthcareResearch
كلية الصيدلة 🚺|
من منّا من لا تُشكل له البدايات الجديدة توجُّس و مَهَابَة؟ ومن منّا لا يترددُ كثيرًا حين تَكثُر أمامه الخيارات والسُبل؟!
كونوا معنا فِي نشَاطنا القادم "يممّ" الذي نأملُ من خِلاله سدَ ثغرات التِيه لمن يستقبلُ صفحة أخرى في مسيرةِ تجربتهِ العلمية والمِهنية🤩
كلية الصيدلة 🚺
نزلنا لأرض الواقع، وسألنا طلابنا عن معاني بعض المصطلحات الطبية وكيف ممكن يشرحوها للمرضى؛ والنتيجة ...
إنتظروا بسِّطها حتى نعرف أكثر كيف نبسّطها لهم !